Social Media Ideas for Desitination Therapy For Heart Failure

Latest updates for Desitination Therapy For Heart Failure

Fresh curated links around desitination therapy for heart failure are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

drsvenkatesan.com /1 month ago

How good is Heart mate- 3. as destination therapy in end stage HF . Can it reach Heart transplantation survival rates ?

The primary treatment for end-stage heart failure is heart transplantation, but due to organ shortage and the poor progress in our pursuit for total artificial hearts, LV assist de...

Read source

bioengineer.org /1 month ago

Five-mRNA Cocktail Shows Promise in Reducing Heart Failure Post-Myocardial Infarction

Heart failure following myocardial infarction has long presented a formidable challenge to clinicians worldwide. Despite advances in acute cardiac care, the progression from initia...

Read source

atoday.org /3 weeks ago

New Liver-Directed Chemotherapy Program Offers Hope for Advanced Cancer Patients

LOMA LINDA, CA – Loma Linda University Health has successfully launched a new treatment option for patients with advanced colorectal cancer, with 47-year-old David Gutierrez becomi...

Read source

refractor.io /1 week ago

Three-in-one pill cuts heart failure hospitalizations by 60%

A novel three-in-one medication known as a "polypill" has been put to the test in a trial of more than 200 heart failure patients, in an effort to find a new way to effectively tre...

Read source

biopharmadive.com /4 weeks ago

Edgewise heart drug passes key trial test

Still, the results leave somewhat unclear how different the company’s drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics.

Read source

scitechdaily.com /1 month ago

10-Cent Pill Could Transform Heart Failure Treatment Worldwide

New research indicates that low-dose digoxin may provide significant benefits for heart failure patients. A low dose of digoxin may help people with heart failure avoid hospitaliza...

Read source

medcitynews.com /6 days ago

Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease Market

AstraZeneca and Ionis Pharmaceuticals drug eplontersen, brand name Wainua, failed a Phase 3 test in cardiomyopathy caused by transthyretin amyloidosis. More details will be shared...

Read source

newsonjapan.com /3 weeks ago

First Approval for Heart Tissue Reuse in Japan

A new treatment that uses healthy tissue from the heart removed from a transplant patient and transplants it into another patient has been approved in Japan for the first time, wit...

Read source

biopharmadive.com /1 week ago

AstraZeneca, Ionis drug fails big heart disease study in major setback

Eplontersen’s failure in transthyretin-mediated amyloidosis cardiomyopathy caught Wall Street analysts by surprise and boosted the outlook of rival drugs from Alnylam and BridgeBio...

Read source

healio.com /1 month ago

Immunotherapy combination may improve liver cancer outcomes

CHICAGO — Adding an immunotherapy-based regimen to standard treatment may improve outcomes for some patients with liver cancer who are not candidates for surgery, according to resu...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.